Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007
- PMID: 31440945
- DOI: 10.1007/s11102-019-00983-7
Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007
Abstract
Purpose: Childhood-onset craniopharyngiomas (CP) are diagnosed due to clinical symptoms (symCP) or incidentally (incCP). We investigated clinical manifestations and outcome in incCPs and symCPs.
Methods: IncCP were discovered in 4 (3 m/1 f) and symCP in 214 (101 m/113 f) CP recruited 2007-2014 in KRANIOPHARYNGEOM 2007. Age, sex, height, body mass index (BMI), tumor volume, degree of resection, pre- and postsurgical hypothalamic involvement/lesions, pituitary function and outcome were compared between both subgroups.
Results: Reasons for imaging in incCP were cerebral palsy, head trauma, nasal obstruction, and tethered-cord syndrome, whereas headache (44%), visual impairment (25%), and growth retardation (17%) lead to imaging in symCP. Tumor volume at diagnosis was smaller in incCP (median 2.39 cm3; range 0.14-4.10 cm3) when compared with symCP (15.86 cm3; 0.002-286.34 cm3). Age, gender, BMI, height, hydrocephalus, tumor location, and hypothalamic involvement at diagnosis of incCP were within the range of these parameters in symCP. Complete resections were achieved more frequently (3/4 patients) in incCP when compared with symCP (20%). Surgical hypothalamic lesions were distributed similar in incCP and symCP. Irradiation was performed only in symCP (33%). No noticeable differences were observed concerning survival rates, endocrine deficiencies, BMI, height, functional capacity and quality of life of the 4 incCP cases when compared with the symCP cohort.
Conclusions: IncCP are rare (1.8%) and characterized by lack of endocrine deficiencies, resulting in normal height and BMI, no hydrocephalus, and smaller tumor volume at diagnosis when compared with symCPs. Outcome of the observed incCP is similar with symCP.
Clinical trial registration number: NCT01272622.
Keywords: Craniopharyngioma; Hypothalamus; Incidentaloma; Pituitary; Quality of life.
Similar articles
-
History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis.Eur J Endocrinol. 2015 Dec;173(6):853-62. doi: 10.1530/EJE-15-0709. Epub 2015 Sep 21. Eur J Endocrinol. 2015. PMID: 26392473
-
Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life.Klin Padiatr. 2001 Jul-Aug;213(4):244-9. doi: 10.1055/s-2001-16855. Klin Padiatr. 2001. PMID: 11528558
-
Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007.Klin Padiatr. 2014 May;226(3):161-8. doi: 10.1055/s-0034-1368785. Epub 2014 May 12. Klin Padiatr. 2014. PMID: 24819386
-
Craniopharyngioma.Endocr Rev. 2014 Jun;35(3):513-43. doi: 10.1210/er.2013-1115. Epub 2014 Jan 27. Endocr Rev. 2014. PMID: 24467716 Review.
-
Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000.Onkologie. 2005 Mar;28(3):150-6. doi: 10.1159/000083671. Onkologie. 2005. PMID: 15772466 Review.
Cited by
-
Application of Artificial Intelligence in Diagnosis of Craniopharyngioma.Front Neurol. 2022 Jan 6;12:752119. doi: 10.3389/fneur.2021.752119. eCollection 2021. Front Neurol. 2022. PMID: 35069406 Free PMC article. Review.
-
Hypopituitarism in non-neuroendocrine pituitary tumors: a systematic review.Rev Endocr Metab Disord. 2025 Aug;26(4):641-657. doi: 10.1007/s11154-025-09969-2. Epub 2025 May 13. Rev Endocr Metab Disord. 2025. PMID: 40360862 Review.
-
Endocrine Disorder in Patients With Craniopharyngioma.Front Neurol. 2021 Dec 2;12:737743. doi: 10.3389/fneur.2021.737743. eCollection 2021. Front Neurol. 2021. PMID: 34925209 Free PMC article. Review.
-
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland.Pituitary. 2024 Dec 26;28(1):5. doi: 10.1007/s11102-024-01490-0. Pituitary. 2024. PMID: 39724307
-
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.Nat Rev Endocrinol. 2025 Jun 24. doi: 10.1038/s41574-025-01134-8. Online ahead of print. Nat Rev Endocrinol. 2025. PMID: 40555795 Review.
References
MeSH terms
Supplementary concepts
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous